07
Aug
EU GMP Annex 11 - Lachman Blog

EU GMP Annex 11: What’s Changing in the 2025 Draft Concept Paper?

While paper trails and legacy systems remain part of the landscape, pharma has been actively coding its next chapter: evolving through digital innovation, transforming core functions like drug development, manufacturing, regulatory oversight, and patient interaction. Central to this is the adoption of advanced technologies such as artificial intelligence (AI), blockchain, cloud computing, and digital twins, […]

Read More
20
Mar
The Strategic Advantage of Implementing a Unified Namespace (UNS) Before Deployment of AI - Lachman Blog

The Strategic Advantage of Implementing a Unified Namespace (UNS) Before Deployment of AI

In today’s rapidly evolving technological landscape, pharma and biotech businesses are increasingly looking to leverage artificial intelligence (AI) to gain a competitive edge. However, before diving headfirst into AI, it is crucial to lay a solid foundation. One of the most effective ways to do this is by implementing a Unified Namespace (UNS). This blog […]

Read More
18
Jul
Delivering your Digital Strategy Key Success Factors - Lachman Blog

Delivering your Digital Strategy: Key Success Factors

As many companies around the world look to upgrade and enhance their IT systems and digital tools, many of these upgrades and implementations have limited success unfortunately. Comprehensive training programs and change management strategies alone are not sufficient. In an era when adoption of digital technologies is key to future competitiveness and company success, the […]

Read More